RGC

About Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Stock

Regencell Bioscience Holdings Limited Ordinary Shares (RGC) closed the 2026-09-17 session at $5.96, up 4.93% versus the previous close (+0.28). The stock opened at $5.75 and traded between $5.60 and $5.97 during that session. Session trading volume was 73K shares. The volume-weighted average price (VWAP) is $5.87.

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Regencell Bioscience Holdings Limited Ordinary Shares has a market capitalization of $2.81 billion. RGC is listed on the XNAS exchange. The company employs approximately 10 people. The recorded listing date is 2021-07-16.

On this page you can find market RGC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.